Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 72 citing articles:

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
Nele Loret, Hannelore Denys, Philippe Tummers, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 838-838
Open Access | Times Cited: 211
Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
Lorena Ávila-Carrasco, Pedro Majano, José Antonio Sánchez-Tomero, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 176
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Vu H. Nguyen, Rebecca Hough, Stefanie Bernaudo, et al.
Journal of Ovarian Research (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 162
Chemical Structures and Pharmacological Profiles of Ginseng Saponins
Zeyu Shi, Jin-Zhang Zeng, Alice S.T. Wong
Molecules (2019) Vol. 24, Iss. 13, pp. 2443-2443
Open Access | Times Cited: 145
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Charli Dominguez, Justin M. David, Claudia Palena
Seminars in Cancer Biology (2017) Vol. 47, pp. 177-184
Open Access | Times Cited: 127
Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy
Devesh Tewari, Sweta Bawari, Shikha Sharma, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107876-107876
Closed Access | Times Cited: 62
Herb–drug interactions between Panax notoginseng or its biologically active compounds and therapeutic drugs: A comprehensive pharmacodynamic and pharmacokinetic review
Yujuan Xie, Changhong Wang
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116156-116156
Closed Access | Times Cited: 39
Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update
Jose Antonio Valdés-González, Marta Sánchez, Ignacio Moratilla-Rivera, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3863-3863
Open Access | Times Cited: 36
Targeting ovarian cancer stem cells: a new way out
Huiying Ma, Tian Tian, Zhumei Cui
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration
Keke Li, Jiwen Li, Zhongyu Li, et al.
Pharmacological Research (2024) Vol. 203, pp. 107175-107175
Open Access | Times Cited: 10
The Emerging Role of Natural Products in Cancer Treatment
Sumit Ghosh, Sanjib Das, Krishnendu Sinha, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2353-2391
Closed Access | Times Cited: 10
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 9
Hepataprotective effects of ginsenoside Rg1 – A review
Yan Gao, Shifeng Chu, Zhao Zhang, et al.
Journal of Ethnopharmacology (2017) Vol. 206, pp. 178-183
Closed Access | Times Cited: 79
Targeting molecular pathways in cancer stem cells by natural bioactive compounds
Danila Cianciosi, Alfonso Varela‐López, Tamara Y. Forbes‐Hernández, et al.
Pharmacological Research (2018) Vol. 135, pp. 150-165
Closed Access | Times Cited: 67
The use of natural compounds for the targeting and chemoprevention of ovarian cancer
Francesca Pistollato, Rubén Calderón Iglesias, Roberto Ruíz, et al.
Cancer Letters (2017) Vol. 411, pp. 191-200
Closed Access | Times Cited: 65
Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development
Piyush Kumar Gupta, Mrunmayee Saraff, Rekha Gahtori, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 676-676
Open Access | Times Cited: 51
Panax notoginseng: Pharmacological Aspects and Toxicological Issues
Cesare Mancuso
Nutrients (2024) Vol. 16, Iss. 13, pp. 2120-2120
Open Access | Times Cited: 6
Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
Ainaz Mihanfar, Javad Aghazadeh Attari, Iraj Mohebbi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 4, pp. 3238-3253
Closed Access | Times Cited: 52
Cancer chemoprevention and therapy using chinese herbal medicine
Lijing Jiao, Ling Bi, Yan Lu, et al.
Biological Procedures Online (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 51
Ovarian cancer stem cells: What progress have we made?
Linah Al-Alem, Unnati M. Pandya, Andrew T. Baker, et al.
The International Journal of Biochemistry & Cell Biology (2018) Vol. 107, pp. 92-103
Closed Access | Times Cited: 49
The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
Vanessa Castelli, Antonio Giordano, Elisabetta Benedetti, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 328-328
Open Access | Times Cited: 34
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Saponins as cytotoxic agents: an update (2010–2021). Part II—Triterpene saponins
Irma Podolak, Karolina Grabowska, Danuta Sobolewska, et al.
Phytochemistry Reviews (2022) Vol. 22, Iss. 1, pp. 113-167
Open Access | Times Cited: 26
Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis
Jinlong Liu, Yuchen Wang, Zhun Yu, et al.
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 23
MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
Songshu Xiao, Yueran Li, Qiong Pan, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 3, pp. 2940-2953
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top